Developer docs
API playgroundTry for free, no card

Search company profiles

23Mofang

Full company profile

uuid00035jk

Namestring
23Mofang
Legal namestring
23魔方
Websiteurl
23mofang.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

23Mofang is a Chengdu-based, privately held direct-to-consumer genetic testing company founded in 2015 and operating exclusively in the Chinese domestic market. The company sells saliva-based DNA test kits through its own e-commerce site, a dedicated mobile application, and flagship stores on JD.com and Tmall, offering product tiers spanning basic ancestry and trait analysis (¥499), standard health-plus-ancestry kits (¥699–¥1,448), specialized deep panels for hereditary cancer and cardiovascular disease (¥999 each), non-invasive colorectal cancer screening (¥599), and higher-value reproductive carrier screening marketed as "芙安孕" (¥2,999 single, ¥4,999 couple). Customer segments are horizontal — health-conscious individuals, ancestry and heritage enthusiasts, and couples planning pregnancy — with no enterprise or institutional channel disclosed.

The underlying technology stack is NGS whole-gene large panel sequencing that interrogates up to 80 million genetic loci per sample at greater than 99% validated accuracy, layered with proprietary Polygenic Risk Score (PRS) models and genetic markers specifically curated against Chinese population research literature. The company operates a nationally certified clinical medical laboratory (国家认证临床医学检验所) and has built a proprietary database exceeding 1 million genetic profiles, 100,000+ family records, 55,477 genealogical entries, and 1,066 surnames, which powers ancillary products including a Y-chromosome paternal lineage tracer, a gene-based relative-finding platform (魔方寻亲), and 1-on-1 ancestry consultation services. Core strategic partnerships include Thermo Fisher Scientific (sequencing infrastructure), Fudan University's Modern Human Biology Key Laboratory, the Chinese Academy of Sciences Kunming Institute of Zoology, and the Medical Genetics Center of the First Affiliated Hospital of Army Medical University.

Revenue mechanics are one-time kit sales with no subscription component in the disclosed catalog; results are delivered digitally via the mobile app approximately two weeks after the laboratory receives the saliva sample, and the company states it continuously updates prior results as research and algorithms improve. The company has disclosed roughly $24.5 million in cumulative equity funding across 2017–2018 rounds led by Matrix Partners China alongside Hanwang Technology, Yahui Precision Medicine Fund, Chengdu Deshang Qidian, and Fenghou Capital, with co-founder Zhou Kun serving as chief executive.

Short descriptiontext

23Mofang is a Chengdu-based direct-to-consumer genetic testing company selling saliva-based ancestry, health-risk, and reproductive carrier screening kits to Chinese consumers through owned e-commerce, mobile app, and JD/Tmall storefronts, powered by NGS sequencing and a proprietary 1M+ profile database.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChengdu, China
HQ citystring
Chengdu
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
consumer genetic testing, DNA ancestry testing, hereditary disease screening, carrier screening services, personal genomics
Industry2 codes
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Testing Laboratories8734
Product category
Consumer Genetic Testing Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct-to-Consumer Genetic Test Kit Sales
TypeOne Time License
Description

23Mofang generates revenue primarily through the one-time sale of genetic testing kits to individual consumers. Each kit represents a single transaction for DNA collection and analysis, with results delivered digitally via the company's mobile app. The company offers multiple product tiers ranging from basic ancestry-only tests to comprehensive health and ancestry combination packages.

23mofang.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details10 tiers
123魔方个人基因检测5 (Standard) - ¥699
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Main product covering 10 categories, hundreds of genetic testing items across health, ancestry, and traits. Listed at ¥699 (original price ¥799). Includes ancestry, genetic disease risks, physiological traits, psychological/cognitive traits, dietary habits, nutritional needs, medication safety, fitness, skin management, and genetic disease screening.

23mofang.com
223魔方个人基因检测 特质版 (Traits Version) - ¥499
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Entry-level ancestry and traits version without the full health risk panel. Covers basic ancestry components, mother-line migration, and selected trait categories.

23mofang.com
323魔方个人基因检测 祖源版 (Ancestry Version) - ¥499
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Ancestry-focused version covering ethnic composition detection, maternal lineage, and genetic relative matching. Excludes comprehensive health risk panels.

23mofang.com
4祖源健康组合装5 (Ancestry + Health Combo V5) - ¥1448
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Combined ancestry and health testing package, offering more comprehensive coverage than the standard kit. Bundles the full health and ancestry testing capabilities.

23mofang.com
5父系祖源深度检测 (Paternal Ancestry Deep Detection) - ¥899
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Deep paternal ancestry testing using Y-chromosome markers. Only available for male users due to the Y-chromosome requirement. Provides comprehensive Y-chromosome history, surname origin research, clan differentiation tree, and paternal relative matching.

23mofang.com
623魔方遗传性肿瘤深度检测 (Hereditary Cancer Deep Detection) - ¥999
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

NGS-based deep detection for hereditary cancer risk, targeting 6 hereditary tumor types including breast cancer, gastric cancer, prostate cancer, pancreatic cancer, colorectal cancer, and gastrointestinal stromal tumor.

23mofang.com
7遗传性心血管疾病深度检测 (Hereditary Cardiovascular Disease Deep Detection) - ¥999
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

NGS-based deep detection for hereditary cardiovascular disease risks.

23mofang.com
8结直肠癌早期无创检测 (Colorectal Cancer Early Non-Invasive Detection) - ¥599
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Non-invasive early screening test for colorectal cancer using a saliva sample.

23mofang.com
923魔方「芙安孕」单基因遗传病携带者筛查-单人版 (Carrier Screening Single) - ¥2999
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Single-person version of single-gene hereditary disease carrier screening, designed for couples planning pregnancy to assess risk of passing genetic disorders to offspring.

23mofang.com
1023魔方「芙安孕」单基因遗传病携带者筛查-夫妻版 (Carrier Screening Couple) - ¥4999
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Couple version of single-gene hereditary disease carrier screening, providing comprehensive assessment for both partners planning pregnancy.

23mofang.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1魔方寻亲
Description

A platform for people separated from family members to register for reunion matching, leveraging 23魔方's genetic database to connect individuals with biological relatives.

23mofang.com
Core offering1 text field

23Mofang sells at-home saliva-based genetic testing kits directly to Chinese consumers, capturing ancestry composition, disease risk, traits, and carrier status via NGS whole-gene sequencing. Customers collect 2mL of saliva at home, mail it back to a nationally certified clinical lab, and receive digital results within approximately 2 weeks through the 23Mofang mobile app. The portfolio ranges from ¥499 ancestry-only tests to ¥4,999 couple-based preconception carrier screening, distributed via 23mofang.com, the company app, JD.com, and Tmall.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Detection accuracy exceeding 99% validated through experimental verification of the NGS whole-gene large panel sequencing technology
+3 more records
Product overview1 text field

23Mofang operates as a comprehensive direct-to-consumer genetic testing platform offering multiple product tiers. The core offering is the 23魔方个人基因检测5 (Personal Genetic Testing 5) at ¥699, which uses NGS-based whole-genome large panel sequencing to detect 80+ million genetic loci with >99% accuracy. The product portfolio spans three main categories: (1) ancestry testing (祖源版, 父系祖源深度检测) covering ethnic composition for 40+ populations, surname/family/genealogy libraries, Y-chromosome trees, and gene-based relative finding; (2) health testing including 54 genetic disease risks (6 hereditary tumors + 48 common diseases), carrier screening for 13 genetic diseases, and specialized deep tests for hereditary cancer and cardiovascular disease; and (3) trait testing covering physiological traits, dietary habits, fitness, and skin management. Add-on products include trait-specific versions (¥499), ancestry+health combos (¥1448), colorectal cancer screening (¥599), and carrier screening for pregnancy (¥2999-4999). The platform also provides an ancestry services consulting offering (祖源服务) with expert 1-on-1 guidance and a relative-finding platform (魔方寻亲) leveraging a million-person genetic database.

Product and service12 records
123Mofang Personal Genetic Testing 5 (23魔方个人基因检测5)
CategoryConsumer Genetic Testing
Description

23Mofang's flagship comprehensive personal genetic testing kit using NGS whole-gene large-panel sequencing to detect up to 80M loci with >99% accuracy. Covers ancestry, disease risk, traits, nutrition, medication, fitness, skin, and carrier screening. Sold to individual consumers at ¥699.

223Mofang Personal Genetic Testing - Trait Version (特质版)
CategoryConsumer Genetic Testing
Description

Entry-level kit focused on consumer traits such as physiological traits, dietary habits, fitness potential, and skin characteristics. Priced at ¥499 for individual consumers who do not require the full health risk panel.

323Mofang Personal Genetic Testing - Ancestry Version (祖源版)
CategoryConsumer Genetic Testing
Description

DNA testing kit focused on ethnic composition analysis for 40+ populations, surname library access, family library, genealogy library, Y-chromosome marker tree, and gene-based relative finding. Priced at ¥499 for individual consumers.

4Ancestry + Health Combo 5 (祖源健康组合装5)
CategoryConsumer Genetic Testing
Description

Combined ancestry and health package bundling comprehensive ancestry exploration with full health risk assessment. Sold for ¥1,448 to individual consumers.

5Paternal Ancestry Deep Testing (父系祖源深度检测)
CategoryConsumer Genetic Testing
Description

Deep paternal ancestry test requiring Y-chromosome analysis. Maps Y-chromosome marker history spanning 2,300–18,000 years and produces family differentiation trees. Available exclusively to male consumers at ¥899.

623Mofang Hereditary Cancer Deep Testing (23魔方遗传性肿瘤深度检测)
CategoryConsumer Genetic Testing
Description

NGS-based deep test for hereditary cancer risk covering breast, gastric, prostate, pancreatic, colorectal, and gastrointestinal stromal tumors. Priced at ¥999 for individual consumers seeking specialized hereditary tumor screening.

7Hereditary Cardiovascular Disease Deep Testing (遗传性心血管疾病深度检测)
CategoryConsumer Genetic Testing
Description

NGS-based deep test for hereditary cardiovascular disease risk, providing detailed genetic risk assessment for cardiovascular conditions. Priced at ¥999 for individual consumers.

8Colorectal Cancer Early Non-invasive Testing (结直肠癌早期无创检测)
CategoryConsumer Genetic Testing
Description

Non-invasive early screening test for colorectal cancer using a saliva sample. Priced at ¥599 for individual consumers seeking accessible colorectal cancer screening.

923Mofang 'Fu Anyun' Single-Gene Hereditary Disease Carrier Screening - Single Version (芙安孕)
CategoryConsumer Genetic Testing
Description

Preconception carrier screening for single-gene hereditary diseases for individual testing, designed to identify genetic disease carriers before family planning. Priced at ¥2,999.

1023Mofang 'Fu Anyun' Single-Gene Hereditary Disease Carrier Screening - Couple Version (芙安孕)
CategoryConsumer Genetic Testing
Description

Couple-level preconception carrier screening for single-gene hereditary diseases, providing combined genetic risk assessment for two partners planning pregnancy. Priced at ¥4,999.

11Mofang Relative Finding (魔方寻亲)
CategoryConsumer Genetic Testing
Description

Online platform for separated family members to register for genetic-based reunion matching, leveraging 23Mofang's million-level genetic database to connect individuals with biological relatives.

12Ancestry Services (祖源服务)
CategoryConsumer Genetic Testing
Description

Professional ancestry research service offering family origin research, migration history analysis, family verification through genealogy comparison, and personalized family ancestry reports with expert 1-on-1 consultation access.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or Integration
Description

Thermo Fisher Scientific is listed as a partner, providing sequencing technology and equipment that underpins 23Mofang's genetic testing capabilities. As a globally leading life sciences company, Thermo Fisher supplies the technological infrastructure for 23Mofang's NGS-based whole-gene large panel sequencing platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Fudan University's Modern Human Biology Key Laboratory, a Ministry of Education-designated research laboratory, is listed as a research partner. The partnership supports 23Mofang's ancestry research and genetic population studies, contributing academic expertise to the company's Chinese population genetic database.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The research group at the Chinese Academy of Sciences Kunming Institute of Zoology is listed as an academic research partner, contributing expertise in human evolution and disease genomics to support 23Mofang's research capabilities and scientific rigor.

4Army Medical University First Affiliated Hospital Medical Genetics Center (陆军军医大学第一附属医院医学遗传中心)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Medical Genetics Center at the First Affiliated Hospital of Army Medical University is listed as a partner, providing medical genetics expertise to support 23Mofang's hereditary disease screening and health risk assessment capabilities.

23mofang.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based direct-to-consumer genetic testing company offering ancestry, health risk, trait, and carrier-status reports via saliva kits. Closest global analog to 23Mofang in product category and DTC GTM, though 23andMe's reference data is Western-centric while 23Mofang's is China-specific.

TypeDirect peer
Description

China's other leading DTC genetic testing platform, offering ancestry, health, and trait reports with a saliva-based workflow. Most direct domestic competitor to 23Mofang, targeting the same Chinese consumer base with a comparable product portfolio and pricing tiers.

3Ancestry (AncestryDNA)
TypeDirect peer
Description

US-based genealogy-led consumer genomics company; ancestry composition, family-tree integration, and large DNA-matching database. Directly comparable to 23Mofang's ancestry pillar (surname library, family library, Y-chromosome tree, 魔方寻亲) in product and customer use case.

TypeDirect peer
Description

Israel-based DTC genetic testing and online genealogy platform combining DNA test kits with family tree software. Comparable to 23Mofang in the genealogy + DNA-matching intersection, including relative-finding features.

TypeBroad incumbent
Description

China's largest genomics company offering NIPT, clinical sequencing, and population genomics services. Overlaps with 23Mofang in hereditary disease and prenatal testing but operates at much larger scale, primarily B2B and through hospital channels rather than DTC.

TypeBroad incumbent
Description

Chinese clinical genomics company specializing in NIPT and reproductive health diagnostics. Adjacent to 23Mofang's 芙安孕 carrier screening line but serves clinicians and hospitals rather than direct consumers.

TypeEmerging player
Description

US-based DNA sequencing platform operating an app-store model for genetic insights, including health and ancestry applications. Comparable technology architecture (NGS + app-based results delivery) and DTC orientation, but smaller scale and narrower consumer brand.

TypeBroad incumbent
Description

China-based genomics services provider offering sequencing platforms and bioinformatics to research and clinical customers. Shares the NGS technology stack and China footprint with 23Mofang but is primarily B2B rather than DTC.

TypeBroad incumbent
Description

Chinese molecular diagnostics company with broad PCR and genetic testing product lines serving hospitals and clinical labs. Overlaps with 23Mofang in molecular diagnostic capability but distributed through clinical channels at substantially larger scale.

10iCarbonX (碳云智能)
TypeEmerging player
Description

China-based AI-driven health data and 'digital life' platform combining multi-omics, including genetic testing, with consumer-facing health applications. Adjacent to 23Mofang in combining consumer genomics with health interpretation, but broader scope (microbiome, metabolomics) and more platform-oriented model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

23Mofang

Consumer Genetic Testing Services23mofang.com

23Mofang is a Chengdu-based direct-to-consumer genetic testing company selling saliva-based ancestry, health-risk, and reproductive carrier screening kits to Chinese consumers through owned e-commerce, mobile app, and JD/Tmall storefronts, powered by NGS sequencing and a proprietary 1M+ profile database.

What 23Mofang does

23Mofang is a Chengdu-based, privately held direct-to-consumer genetic testing company founded in 2015 and operating exclusively in the Chinese domestic market. The company sells saliva-based DNA test kits through its own e-commerce site, a dedicated mobile application, and flagship stores on JD.com and Tmall, offering product tiers spanning basic ancestry and trait analysis (¥499), standard health-plus-ancestry kits (¥699–¥1,448), specialized deep panels for hereditary cancer and cardiovascular disease (¥999 each), non-invasive colorectal cancer screening (¥599), and higher-value reproductive carrier screening marketed as "芙安孕" (¥2,999 single, ¥4,999 couple). Customer segments are horizontal — health-conscious individuals, ancestry and heritage enthusiasts, and couples planning pregnancy — with no enterprise or institutional channel disclosed.

The underlying technology stack is NGS whole-gene large panel sequencing that interrogates up to 80 million genetic loci per sample at greater than 99% validated accuracy, layered with proprietary Polygenic Risk Score (PRS) models and genetic markers specifically curated against Chinese population research literature. The company operates a nationally certified clinical medical laboratory (国家认证临床医学检验所) and has built a proprietary database exceeding 1 million genetic profiles, 100,000+ family records, 55,477 genealogical entries, and 1,066 surnames, which powers ancillary products including a Y-chromosome paternal lineage tracer, a gene-based relative-finding platform (魔方寻亲), and 1-on-1 ancestry consultation services. Core strategic partnerships include Thermo Fisher Scientific (sequencing infrastructure), Fudan University's Modern Human Biology Key Laboratory, the Chinese Academy of Sciences Kunming Institute of Zoology, and the Medical Genetics Center of the First Affiliated Hospital of Army Medical University.

Revenue mechanics are one-time kit sales with no subscription component in the disclosed catalog; results are delivered digitally via the mobile app approximately two weeks after the laboratory receives the saliva sample, and the company states it continuously updates prior results as research and algorithms improve. The company has disclosed roughly $24.5 million in cumulative equity funding across 2017–2018 rounds led by Matrix Partners China alongside Hanwang Technology, Yahui Precision Medicine Fund, Chengdu Deshang Qidian, and Fenghou Capital, with co-founder Zhou Kun serving as chief executive.

23Mofang firmographics

Firmographics
Name
23Mofang
Legal name
23魔方
Website
https://23mofang.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
23Mofang is a Chengdu-based direct-to-consumer genetic testing company selling saliva-based ancestry, health-risk, and reproductive carrier screening kits to Chinese consumers through owned e-commerce, mobile app, and JD/Tmall storefronts, powered by NGS sequencing and a proprietary 1M+ profile database.
Ownership category
akta.pro rank

23Mofang industry classification

Industry
Product category
Consumer Genetic Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Keywords

  • Consumer genetic testing
  • DNA ancestry testing
  • Hereditary disease screening
  • Carrier screening services
  • Personal genomics

Where 23Mofang is headquartered

Location

Headquarters

HQ city
Chengdu
HQ country
China
HQ region
Asia

Markets served

23Mofang business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Direct-to-Consumer Genetic Test Kit Sales: 23Mofang generates revenue primarily through the one-time sale of genetic testing kits to individual consumers. Each kit represents a single transaction for DNA collection and analysis, with results delivered digitally via the company's mobile app. The company offers multiple product tiers ranging from basic ancestry-only tests to comprehensive health and ancestry combination packages.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-go23魔方个人基因检测5 (Standard) - ¥699
One time/ perpetual licensePay-as-you-go23魔方个人基因检测 特质版 (Traits Version) - ¥499
One time/ perpetual licensePay-as-you-go23魔方个人基因检测 祖源版 (Ancestry Version) - ¥499
One time/ perpetual licensePay-as-you-go祖源健康组合装5 (Ancestry + Health Combo V5) - ¥1448
One time/ perpetual licensePay-as-you-go父系祖源深度检测 (Paternal Ancestry Deep Detection) - ¥899
One time/ perpetual licensePay-as-you-go23魔方遗传性肿瘤深度检测 (Hereditary Cancer Deep Detection) - ¥999
One time/ perpetual licensePay-as-you-go遗传性心血管疾病深度检测 (Hereditary Cardiovascular Disease Deep Detection) - ¥999
One time/ perpetual licensePay-as-you-go结直肠癌早期无创检测 (Colorectal Cancer Early Non-Invasive Detection) - ¥599
One time/ perpetual licensePay-as-you-go23魔方「芙安孕」单基因遗传病携带者筛查-单人版 (Carrier Screening Single) - ¥2999
One time/ perpetual licensePay-as-you-go23魔方「芙安孕」单基因遗传病携带者筛查-夫妻版 (Carrier Screening Couple) - ¥4999

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

23Mofang product offering

Product offering

Core offering

23Mofang sells at-home saliva-based genetic testing kits directly to Chinese consumers, capturing ancestry composition, disease risk, traits, and carrier status via NGS whole-gene sequencing. Customers collect 2mL of saliva at home, mail it back to a nationally certified clinical lab, and receive digital results within approximately 2 weeks through the 23Mofang mobile app. The portfolio ranges from ¥499 ancestry-only tests to ¥4,999 couple-based preconception carrier screening, distributed via 23mofang.com, the company app, JD.com, and Tmall.

Product overview

23Mofang operates as a comprehensive direct-to-consumer genetic testing platform offering multiple product tiers. The core offering is the 23魔方个人基因检测5 (Personal Genetic Testing 5) at ¥699, which uses NGS-based whole-genome large panel sequencing to detect 80+ million genetic loci with >99% accuracy. The product portfolio spans three main categories: (1) ancestry testing (祖源版, 父系祖源深度检测) covering ethnic composition for 40+ populations, surname/family/genealogy libraries, Y-chromosome trees, and gene-based relative finding; (2) health testing including 54 genetic disease risks (6 hereditary tumors + 48 common diseases), carrier screening for 13 genetic diseases, and specialized deep tests for hereditary cancer and cardiovascular disease; and (3) trait testing covering physiological traits, dietary habits, fitness, and skin management. Add-on products include trait-specific versions (¥499), ancestry+health combos (¥1448), colorectal cancer screening (¥599), and carrier screening for pregnancy (¥2999-4999). The platform also provides an ancestry services consulting offering (祖源服务) with expert 1-on-1 guidance and a relative-finding platform (魔方寻亲) leveraging a million-person genetic database.

Differentiator

Problem solved

Functional benefit

Brands

  • 魔方寻亲: A platform for people separated from family members to register for reunion matching, leveraging 23魔方's genetic database to connect individuals with biological relatives.

Products and services

  • 23Mofang Personal Genetic Testing 5 (23魔方个人基因检测5) 23Mofang's flagship comprehensive personal genetic testing kit using NGS whole-gene large-panel sequencing to detect up to 80M loci with >99% accuracy. Covers ancestry, disease risk, traits, nutrition, medication, fitness, skin, and carrier screening. Sold to individual consumers at ¥699.
  • 23Mofang Personal Genetic Testing - Trait Version (特质版) Entry-level kit focused on consumer traits such as physiological traits, dietary habits, fitness potential, and skin characteristics. Priced at ¥499 for individual consumers who do not require the full health risk panel.
  • 23Mofang Personal Genetic Testing - Ancestry Version (祖源版) DNA testing kit focused on ethnic composition analysis for 40+ populations, surname library access, family library, genealogy library, Y-chromosome marker tree, and gene-based relative finding. Priced at ¥499 for individual consumers.
  • Ancestry + Health Combo 5 (祖源健康组合装5) Combined ancestry and health package bundling comprehensive ancestry exploration with full health risk assessment. Sold for ¥1,448 to individual consumers.
  • Paternal Ancestry Deep Testing (父系祖源深度检测) Deep paternal ancestry test requiring Y-chromosome analysis. Maps Y-chromosome marker history spanning 2,300–18,000 years and produces family differentiation trees. Available exclusively to male consumers at ¥899.
  • 23Mofang Hereditary Cancer Deep Testing (23魔方遗传性肿瘤深度检测) NGS-based deep test for hereditary cancer risk covering breast, gastric, prostate, pancreatic, colorectal, and gastrointestinal stromal tumors. Priced at ¥999 for individual consumers seeking specialized hereditary tumor screening.
  • Hereditary Cardiovascular Disease Deep Testing (遗传性心血管疾病深度检测) NGS-based deep test for hereditary cardiovascular disease risk, providing detailed genetic risk assessment for cardiovascular conditions. Priced at ¥999 for individual consumers.
  • Colorectal Cancer Early Non-invasive Testing (结直肠癌早期无创检测) Non-invasive early screening test for colorectal cancer using a saliva sample. Priced at ¥599 for individual consumers seeking accessible colorectal cancer screening.
  • 23Mofang 'Fu Anyun' Single-Gene Hereditary Disease Carrier Screening - Single Version (芙安孕) Preconception carrier screening for single-gene hereditary diseases for individual testing, designed to identify genetic disease carriers before family planning. Priced at ¥2,999.
  • 23Mofang 'Fu Anyun' Single-Gene Hereditary Disease Carrier Screening - Couple Version (芙安孕) Couple-level preconception carrier screening for single-gene hereditary diseases, providing combined genetic risk assessment for two partners planning pregnancy. Priced at ¥4,999.
  • Mofang Relative Finding (魔方寻亲) Online platform for separated family members to register for genetic-based reunion matching, leveraging 23Mofang's million-level genetic database to connect individuals with biological relatives.
  • Ancestry Services (祖源服务) Professional ancestry research service offering family origin research, migration history analysis, family verification through genealogy comparison, and personalized family ancestry reports with expert 1-on-1 consultation access.

Quantifiable outcome

  • Detection accuracy exceeding 99% validated through experimental verification of the NGS whole-gene large panel sequencing technology
  • +3 more outcomes

Companies that use 23Mofang

Customer profile

Segments3 records

Ideal customer profiles3 records

23Mofang technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

23Mofang partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Thermo Fisher ScientificcoreTechnology or IntegrationThermo Fisher Scientific is listed as a partner, providing sequencing technology and equipment that underpins 23Mofang's genetic testing capabilities. As a globally leading life sciences company, Thermo Fisher supplies the technological infrastructure for 23Mofang's NGS-based whole-gene large panel sequencing platform.
  • Fudan University Modern Human Biology Key Laboratory (复旦大学现代人类学教育部重点实验室)coreStrategic or Co-development PartnerFudan University's Modern Human Biology Key Laboratory, a Ministry of Education-designated research laboratory, is listed as a research partner. The partnership supports 23Mofang's ancestry research and genetic population studies, contributing academic expertise to the company's Chinese population genetic database.
  • Chinese Academy of Sciences Kunming Institute of Zoology - Human Evolution and Disease Genome Research Group (中国科学院昆明动物研究所人类进化与疾病基因组学研究组)coreStrategic or Co-development PartnerThe research group at the Chinese Academy of Sciences Kunming Institute of Zoology is listed as an academic research partner, contributing expertise in human evolution and disease genomics to support 23Mofang's research capabilities and scientific rigor.
  • Army Medical University First Affiliated Hospital Medical Genetics Center (陆军军医大学第一附属医院医学遗传中心)coreStrategic or Co-development PartnerThe Medical Genetics Center at the First Affiliated Hospital of Army Medical University is listed as a partner, providing medical genetics expertise to support 23Mofang's hereditary disease screening and health risk assessment capabilities.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

23Mofang competitors and assessment

Company assessment

Direct peers

  • 23andMe: US-based direct-to-consumer genetic testing company offering ancestry, health risk, trait, and carrier-status reports via saliva kits. Closest global analog to 23Mofang in product category and DTC GTM, though 23andMe's reference data is Western-centric while 23Mofang's is China-specific.
  • WeGene (微基因): China's other leading DTC genetic testing platform, offering ancestry, health, and trait reports with a saliva-based workflow. Most direct domestic competitor to 23Mofang, targeting the same Chinese consumer base with a comparable product portfolio and pricing tiers.
  • Ancestry (AncestryDNA): US-based genealogy-led consumer genomics company; ancestry composition, family-tree integration, and large DNA-matching database. Directly comparable to 23Mofang's ancestry pillar (surname library, family library, Y-chromosome tree, 魔方寻亲) in product and customer use case.
  • MyHeritage: Israel-based DTC genetic testing and online genealogy platform combining DNA test kits with family tree software. Comparable to 23Mofang in the genealogy + DNA-matching intersection, including relative-finding features.

Broad incumbents

  • BGI Genomics (华大基因): China's largest genomics company offering NIPT, clinical sequencing, and population genomics services. Overlaps with 23Mofang in hereditary disease and prenatal testing but operates at much larger scale, primarily B2B and through hospital channels rather than DTC.
  • Berry Genomics (贝瑞和康): Chinese clinical genomics company specializing in NIPT and reproductive health diagnostics. Adjacent to 23Mofang's 芙安孕 carrier screening line but serves clinicians and hospitals rather than direct consumers.
  • Novogene (诺禾致源): China-based genomics services provider offering sequencing platforms and bioinformatics to research and clinical customers. Shares the NGS technology stack and China footprint with 23Mofang but is primarily B2B rather than DTC.
  • Daan Gene (达安基因): Chinese molecular diagnostics company with broad PCR and genetic testing product lines serving hospitals and clinical labs. Overlaps with 23Mofang in molecular diagnostic capability but distributed through clinical channels at substantially larger scale.

Emerging players

  • Helix: US-based DNA sequencing platform operating an app-store model for genetic insights, including health and ancestry applications. Comparable technology architecture (NGS + app-based results delivery) and DTC orientation, but smaller scale and narrower consumer brand.
  • iCarbonX (碳云智能): China-based AI-driven health data and 'digital life' platform combining multi-omics, including genetic testing, with consumer-facing health applications. Adjacent to 23Mofang in combining consumer genomics with health interpretation, but broader scope (microbiome, metabolomics) and more platform-oriented model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

23Mofang social profiles

Digital presence

23Mofang compliance and trust

Trust signal

Compliance1 record

23Mofang financial estimates

Financial estimate

Revenue estimate

Valuation estimate

23Mofang leadership team

Management profile

Number of profiles

Profiles1 record

23Mofang funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

23Mofang M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 23Mofang

What does 23Mofang do?

23Mofang sells at-home saliva-based genetic testing kits directly to Chinese consumers, capturing ancestry composition, disease risk, traits, and carrier status via NGS whole-gene sequencing. Customers collect 2mL of saliva at home, mail it back to a nationally certified clinical lab, and receive digital results within approximately 2 weeks through the 23Mofang mobile app. The portfolio ranges from ¥499 ancestry-only tests to ¥4,999 couple-based preconception carrier screening, distributed via 23mofang.com, the company app, JD.com, and Tmall.

Is 23Mofang a public or private company?

23Mofang is a private company. It is classified as venture growth investor backed and is currently operating.

When was 23Mofang founded?

23Mofang was founded in 2015. It employs 11 to 50 people.

Where is 23Mofang based?

23Mofang is headquartered in Chengdu, China, in the Asia region.

How does 23Mofang make money?

One revenue line is on record: direct-to-Consumer Genetic Test Kit Sales.

Who are 23Mofang's main competitors?

Direct peers on record are 23andMe, WeGene (微基因), Ancestry (AncestryDNA) and MyHeritage. Broad incumbents are BGI Genomics (华大基因), Berry Genomics (贝瑞和康), Novogene (诺禾致源) and Daan Gene (达安基因). Emerging players are Helix and iCarbonX (碳云智能).

Does 23Mofang have an API?

No public API is recorded for 23Mofang.

What industry is 23Mofang in?

23Mofang's product category is Consumer Genetic Testing Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621511 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
South China Morning PostDNA Dilemmas: How Consumer Genetic Testing Compares in the US and China -Consumer genetic testing in the US and China is compared, with China's WeGene using WeChat and 68.7% of tests sold via social media. Privacy risks are highlighted, including 47% of Chinese apps lacking clear policies and 33.7% of test-taker data sold to third parties. The article notes China's stricter data laws versus US state-level rules.South China Morning PostAs demand for genetic testing grows in China, start-up 23Mofang can now tell if you have royal bloodChinese genetic testing company 23Mofang offers a saliva-based test for 449 yuan that includes ancestral information and can determine if a user is a descendant of ancient Chinese royalty. The company estimates 1.81% of China's population, about 25.3 million people, are descendants of Emperor Gaozu Liu Bang. The genetic testing market has grown rapidly, with 26 million consumers taking tests at the start of this year.PR NewswireChengdu Tianfu Software Park Reflects the Vitality of IP InnovationChengdu 23Mofang Bio-tech Company, a startup based in Chengdu Tianfu Software Park, has published an academic paper on genome-wide association study of photic sneeze reflex in the Chinese population in the Scientific Reports journal under Nature. The study, conducted in collaboration with Sichuan University's West China School of Public Health, is the first to prove the hereditary nature of photic sneeze reflex across multiple populations. The article highlights the park's role as an innovation hub, noting that enterprises within Tianfu Software Park have applied for over 22,000 patents and possess more than 19,500 software copyrights.TechNodeThe first draft of the book of genes will be written in China · TechNode23Mofang, China's largest consumer genetic testing company, offers saliva-based tests for $43, with over 200,000 users. The company's sales have surged a hundred-fold since 2015, and China's large population is expected to produce the first comprehensive draft of the human genome.STATChina embraces a revolution in genetic testing, seeking answers on destiny and identityChinese consumers are increasingly using direct-to-consumer genetic testing, with 23Mofang selling 156,000 kits this year. The company's kits cost under $43, and demand is driven by interest in ancestry, health risks, and lifestyle traits. Newborn sequencing is expected to become a must-have product in the next five years.